Aviral Kumar

1.5k total citations · 2 hit papers
43 papers, 1.1k citations indexed

About

Aviral Kumar is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Aviral Kumar has authored 43 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 10 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Aviral Kumar's work include Curcumin's Biomedical Applications (9 papers), Cancer-related molecular mechanisms research (7 papers) and MicroRNA in disease regulation (5 papers). Aviral Kumar is often cited by papers focused on Curcumin's Biomedical Applications (9 papers), Cancer-related molecular mechanisms research (7 papers) and MicroRNA in disease regulation (5 papers). Aviral Kumar collaborates with scholars based in India, Singapore and Saudi Arabia. Aviral Kumar's co-authors include Ajaikumar B. Kunnumakkara, Sosmitha Girisa, Uzini Devi Daimary, Mangala Hegde, Parama Dey, Gautam Sethi, Mohammed S. Alqahtani, Mohamed Abbas, Choudhary Harsha and Alan Prem Kumar and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Aviral Kumar

43 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pulsed electric field (PEF): Avant-garde extraction escalation technology in food industry

2022 118 citations Aviral Kumar, Sosmitha Girisa et al. profile →
Role of Turmeric and Curcumin in Prevention and Treatment of Chronic Diseases: Lessons Learned from Clinical Trials

2023 115 citations Ajaikumar B. Kunnumakkara, Mangala Hegde et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Aviral Kumar India	21	512	217	151	131	100	43	1.1k
Tatiana Kalinovsky	21	564 1.1×	298 1.4×	94 0.6×	226 1.7×	104 1.0×	79	1.7k
Tianqi Ming China	11	595 1.2×	201 0.9×	61 0.4×	186 1.4×	105 1.1×	16	1.1k
Vinothkumar Rajamanickam China	23	595 1.2×	155 0.7×	120 0.8×	97 0.7×	102 1.0×	34	1.2k
Piwen Wang United States	23	766 1.5×	241 1.1×	101 0.7×	272 2.1×	125 1.3×	37	1.9k
Mangala Hegde India	17	374 0.7×	91 0.4×	167 1.1×	78 0.6×	69 0.7×	51	967
Monica Benvenuto Italy	22	750 1.5×	137 0.6×	167 1.1×	279 2.1×	138 1.4×	53	1.7k
Maolun Liu China	13	710 1.4×	250 1.2×	62 0.4×	223 1.7×	141 1.4×	16	1.3k
Bingtao Zhai China	18	853 1.7×	444 2.0×	100 0.7×	143 1.1×	94 0.9×	52	1.6k
Yueyue Wang China	14	483 0.9×	114 0.5×	85 0.6×	61 0.5×	70 0.7×	35	752

Countries citing papers authored by Aviral Kumar

Since Specialization

Citations

This map shows the geographic impact of Aviral Kumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aviral Kumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aviral Kumar more than expected).

Fields of papers citing papers by Aviral Kumar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aviral Kumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aviral Kumar. The network helps show where Aviral Kumar may publish in the future.

Co-authorship network of co-authors of Aviral Kumar

This figure shows the co-authorship network connecting the top 25 collaborators of Aviral Kumar. A scholar is included among the top collaborators of Aviral Kumar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aviral Kumar. Aviral Kumar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hegde, Mangala, et al.. (2024). Biogenic Synthesis and Characterization of Ethyl Ferulate Gold Nanoparticle and its Efficacy against Triple-Negative Breast Cancer Cells. 15(1). 80–94. 1 indexed citations

Girisa, Sosmitha, Aviral Kumar, Hiu Yan Lam, et al.. (2024). Delineating the role of nuclear receptors in colorectal cancer, a focused review. Discover Oncology. 15(1). 41–41. 5 indexed citations

Chakraborty, Souneek, Aviral Kumar, Yedukondalu Nalli, et al.. (2024). Canonical DDR activation by EMT inducing agent 5-Fluorouracil is modulated by a cannabinoid based combinatorial approach via inducing autophagy and suppression of vimentin expression. Biochemical Pharmacology. 223. 116126–116126. 3 indexed citations

Beevi, Syed Sultan, et al.. (2024). MicroRNA signatures differentiate types, grades, and stages of breast invasive ductal carcinoma (IDC): miRNA-target interacting signaling pathways. Cell Communication and Signaling. 22(1). 100–100. 4 indexed citations

Kumar, Aviral, Sosmitha Girisa, Mohammed S. Alqahtani, et al.. (2023). Targeting Autophagy Using Long Non-Coding RNAs (LncRNAs): New Landscapes in the Arena of Cancer Therapeutics. Cells. 12(5). 810–810. 22 indexed citations

Hegde, Mangala, Aviral Kumar, Sosmitha Girisa, et al.. (2023). Exosomal noncoding RNA-mediated spatiotemporal regulation of lipid metabolism: Implications in immune evasion and chronic inflammation. Cytokine & Growth Factor Reviews. 73. 114–134. 16 indexed citations

Hegde, Mangala, Uzini Devi Daimary, Aviral Kumar, et al.. (2022). Modulation of diverse oncogenic signaling pathways by oroxylin A: An important strategy for both cancer prevention and treatment. Phytomedicine. 105. 154369–154369. 19 indexed citations

Khatoon, Elina, Mangala Hegde, Aviral Kumar, et al.. (2022). The multifaceted role of STAT3 pathway and its implication as a potential therapeutic target in oral cancer. Archives of Pharmacal Research. 45(8). 507–534. 13 indexed citations

Kumar, Aviral, et al.. (2022). Targeting Nuclear Receptors in Lung Cancer—Novel Therapeutic Prospects. Pharmaceuticals. 15(5). 624–624. 20 indexed citations

10.

Hegde, Mangala, Uzini Devi Daimary, Aviral Kumar, et al.. (2022). STAT3/HIF1A and EMT specific transcription factors regulated genes: Novel predictors of breast cancer metastasis. Gene. 818. 146245–146245. 7 indexed citations

11.

Khatoon, Elina, Parama Dey, Aviral Kumar, et al.. (2022). Targeting PD-1/PD-L1 axis as new horizon for ovarian cancer therapy. Life Sciences. 306. 120827–120827. 24 indexed citations

12.

Dey, Parama, Sosmitha Girisa, Elina Khatoon, et al.. (2022). An overview of the pharmacological activities of scopoletin against different chronic diseases. Pharmacological Research. 179. 106202–106202. 28 indexed citations

13.

Dey, Parama, Varsha Rana, Sosmitha Girisa, et al.. (2021). The promising potential of piperlongumine as an emerging therapeutics for cancer. SHILAP Revista de lepidopterología. 2(4). 323–354. 31 indexed citations

14.

Katoch, Archana, Debasis Nayak, Mir Mohd Faheem, et al.. (2021). Natural podophyllotoxin analog 4DPG attenuates EMT and colorectal cancer progression via activation of checkpoint kinase 2. Cell Death Discovery. 7(1). 25–25. 21 indexed citations

15.

Jain, Poonam, Aviral Kumar, Ashok Kumar Jangid, et al.. (2021). Inulin coated Mn3O4 nanocuboids coupled with RNA interference reverse intestinal tumorigenesis in Apc knockout murine colon cancer models. Nanomedicine Nanotechnology Biology and Medicine. 40. 102504–102504. 13 indexed citations

16.

Buhrmann, Constanze, Ajaikumar B. Kunnumakkara, Aviral Kumar, et al.. (2021). Multitargeting Effects of Calebin A on Malignancy of CRC Cells in Multicellular Tumor Microenvironment. Frontiers in Oncology. 11. 650603–650603. 22 indexed citations

17.

Kumar, Aviral. (2020). EMT in breast cancer metastasis an interplay of microRNAs signaling pathways and circulating tumor cells. Frontiers in bioscience. 25(5). 979–1010. 48 indexed citations

18.

Daimary, Uzini Devi, Parama Dey, Varsha Rana, et al.. (2020). Emerging roles of cardamonin, a multitargeted nutraceutical in the prevention and treatment of chronic diseases. SHILAP Revista de lepidopterología. 2. 100008–100008. 39 indexed citations

19.

Chakraborty, Souneek, Aviral Kumar, Mir Mohd Faheem, et al.. (2019). Vimentin activation in early apoptotic cancer cells errands survival pathways during DNA damage inducer CPT treatment in colon carcinoma model. Cell Death and Disease. 10(6). 467–467. 35 indexed citations

20.

Kumar, Aviral, et al.. (2016). Gene therapy as a potential tool for treating neuroblastoma—a focused review. Cancer Gene Therapy. 23(5). 115–124. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact